Charles Schoch is of Candel Therapeutics, Inc.. Currently has a direct ownership of 62,520 shares of CADL, which is worth approximately $302,596. The most recent transaction as insider was on Jul 17, 2024, when has been sold 9,884 shares (Common Stock) at a price of $6.47 per share, resulting in proceeds of $63,949. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 62.5K
0% 3M change
n/a 12M change
Total Value Held $302,596

Charles Schoch Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 17 2024
SELL
Open market or private sale
$63,949 $6.47 p/Share
9,884 Reduced 13.65%
62,520 Common Stock
Jul 11 2024
SELL
Open market or private sale
$53,115 $5.97 p/Share
8,897 Reduced 10.94%
72,404 Common Stock
CS

Charles Schoch

Needham, MA

Track Institutional and Insider Activities on CADL

Follow Candel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CADL shares.

Notify only if

Insider Trading

Get notified when an Candel Therapeutics, Inc. insider buys or sells CADL shares.

Notify only if

News

Receive news related to Candel Therapeutics, Inc.

Track Activities on CADL